$SMLR
Semler Scientific, Inc.

2024 Q4 Form 10-Q Financial Statement

#000155485924000040 Filed on November 05, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $13.51M
YoY Change -17.19%
Cost Of Revenue $1.156M
YoY Change 4.05%
Gross Profit $12.36M
YoY Change -18.74%
Gross Profit Margin 91.44%
Selling, General & Admin $6.105M
YoY Change -14.41%
% of Gross Profit 49.41%
Research & Development $1.186M
YoY Change 1.37%
% of Gross Profit 9.6%
Depreciation & Amortization $134.0K
YoY Change -16.25%
% of Gross Profit 1.08%
Operating Expenses $6.105M
YoY Change -14.41%
Operating Profit $5.065M
YoY Change -19.59%
Interest Expense $168.0K
YoY Change -75.65%
% of Operating Profit 3.32%
Other Income/Expense, Net $1.310M
YoY Change 90.13%
Pretax Income $6.375M
YoY Change -8.77%
Income Tax $766.0K
% Of Pretax Income 12.02%
Net Earnings $5.609M
YoY Change 1.72%
Net Earnings / Revenue 41.51%
Basic Earnings Per Share $0.80
Diluted Earnings Per Share $0.72
COMMON SHARES
Basic Shares Outstanding 7.266M 7.134M
Diluted Shares Outstanding 7.771M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.67M
YoY Change -77.39%
Cash & Equivalents $6.568M
Short-Term Investments $6.100M
Other Short-Term Assets $1.779M
YoY Change -8.77%
Inventory $380.0K
Prepaid Expenses
Receivables $6.667M
Other Receivables $0.00
Total Short-Term Assets $21.49M
YoY Change -66.61%
LONG-TERM ASSETS
Property, Plant & Equipment $2.285M
YoY Change -29.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $512.0K
YoY Change -91.85%
Other Assets $106.0K
YoY Change -96.14%
Total Long-Term Assets $70.70M
YoY Change 369.3%
TOTAL ASSETS
Total Short-Term Assets $21.49M
Total Long-Term Assets $70.70M
Total Assets $92.19M
YoY Change 16.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $545.0K
YoY Change 81.67%
Accrued Expenses $5.258M
YoY Change -24.86%
Deferred Revenue $805.0K
YoY Change -28.13%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.839M
YoY Change -20.26%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change -100.0%
Total Long-Term Liabilities $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.839M
Total Long-Term Liabilities $0.00
Total Liabilities $6.839M
YoY Change -21.12%
SHAREHOLDERS EQUITY
Retained Earnings $71.50M
YoY Change 28.63%
Common Stock $7.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $85.36M
YoY Change
Total Liabilities & Shareholders Equity $92.19M
YoY Change 16.05%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $5.609M
YoY Change 1.72%
Depreciation, Depletion And Amortization $134.0K
YoY Change -16.25%
Cash From Operating Activities $6.425M
YoY Change 33.02%
INVESTING ACTIVITIES
Capital Expenditures $35.00K
YoY Change -76.67%
Acquisitions
YoY Change
Other Investing Activities -$8.400M
YoY Change 26.7%
Cash From Investing Activities -$8.435M
YoY Change 24.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.247M
YoY Change -2594.0%
NET CHANGE
Cash From Operating Activities 6.425M
Cash From Investing Activities -8.435M
Cash From Financing Activities 1.247M
Net Change In Cash -763.0K
YoY Change -61.85%
FREE CASH FLOW
Cash From Operating Activities $6.425M
Capital Expenditures $35.00K
Free Cash Flow $6.390M
YoY Change 36.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001554859
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2024Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2024Q2 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2024#AccountingStandardsUpdate202308Member
us-gaap Crypto Asset Name Extensible Enumeration
CryptoAssetNameExtensibleEnumeration
http://semlerscientific.com/20240930#BitcoinMember
us-gaap Crypto Asset Name Extensible Enumeration
CryptoAssetNameExtensibleEnumeration
http://semlerscientific.com/20240930#BitcoinMember
us-gaap Operating Lease Income Comprehensive Income Extensible List
OperatingLeaseIncomeComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2024#Revenues
CY2023Q3 us-gaap Operating Lease Income Comprehensive Income Extensible List
OperatingLeaseIncomeComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2024#Revenues
us-gaap Operating Lease Income Comprehensive Income Extensible List
OperatingLeaseIncomeComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2024#Revenues
CY2024Q3 us-gaap Operating Lease Income Comprehensive Income Extensible List
OperatingLeaseIncomeComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2024#Revenues
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36305
dei Entity Registrant Name
EntityRegistrantName
SEMLER SCIENTIFIC, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1367393
dei Entity Address Address Line1
EntityAddressAddressLine1
2340-2348 Walsh Avenue, Suite 2344
dei Entity Address City Or Town
EntityAddressCityOrTown
Santa Clara
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95051
dei City Area Code
CityAreaCode
877
dei Local Phone Number
LocalPhoneNumber
774-4211
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
SMLR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7266242
CY2024Q3 us-gaap Revenues
Revenues
13512000
CY2023Q3 us-gaap Revenues
Revenues
16316000
us-gaap Revenues
Revenues
43881000
us-gaap Revenues
Revenues
53127000
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
1156000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
1111000
us-gaap Cost Of Revenue
CostOfRevenue
3657000
us-gaap Cost Of Revenue
CostOfRevenue
3599000
CY2024Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1186000
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1174000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
3764000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4566000
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2976000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3423000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10107000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13601000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3129000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3710000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8962000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11028000
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
599000
us-gaap Restructuring Charges
RestructuringCharges
599000
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
8447000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
10017000
us-gaap Costs And Expenses
CostsAndExpenses
26490000
us-gaap Costs And Expenses
CostsAndExpenses
33393000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
5065000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
6299000
us-gaap Operating Income Loss
OperatingIncomeLoss
17391000
us-gaap Operating Income Loss
OperatingIncomeLoss
19734000
CY2024Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
168000
CY2023Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
692000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1699000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1772000
smlr Fair Value Adjustment Of Notes Held For Investment
FairValueAdjustmentOfNotesHeldForInvestment
-128000
smlr Fair Value Adjustment Of Notes Held For Investment
FairValueAdjustmentOfNotesHeldForInvestment
217000
CY2024Q3 us-gaap Crypto Asset Unrealized Gain Loss Nonoperating
CryptoAssetUnrealizedGainLossNonoperating
1137000
us-gaap Crypto Asset Unrealized Gain Loss Nonoperating
CryptoAssetUnrealizedGainLossNonoperating
-3918000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1310000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
689000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2083000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1552000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6375000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6988000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15308000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
21286000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
766000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1474000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3615000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4924000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
5609000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
5514000
us-gaap Net Income Loss
NetIncomeLoss
11693000
us-gaap Net Income Loss
NetIncomeLoss
16362000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.80
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.82
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.68
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.44
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7045108
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6717301
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6961095
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6708675
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.50
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.09
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7771088
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7818236
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7783350
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7847390
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6568000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57200000
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
133000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
132000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
266000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
287000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6667000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6125000
CY2024Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
6100000
CY2024Q3 us-gaap Inventory Net
InventoryNet
380000
CY2023Q4 us-gaap Inventory Net
InventoryNet
445000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1646000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2042000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
21494000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
65944000
CY2024Q3 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
1737000
CY2023Q4 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
2285000
CY2024Q3 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation
548000
CY2023Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation
720000
CY2024Q3 us-gaap Long Term Investments
LongTermInvestments
512000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
512000
CY2023Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
5372000
CY2024Q3 us-gaap Crypto Asset Fair Value Noncurrent
CryptoAssetFairValueNoncurrent
64482000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
106000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
270000
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
936000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3315000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2962000
CY2024Q3 us-gaap Assets
Assets
92194000
CY2023Q4 us-gaap Assets
Assets
78065000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
545000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
402000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5258000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4502000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
805000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1120000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
231000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
176000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6839000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6200000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
70000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
70000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7334600
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7099441
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7120178
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6885019
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
214422
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
214422
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
7000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
7000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13852000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11985000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
71496000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
59803000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
85355000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
71795000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
92194000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
78065000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
65263000
CY2023Q3 smlr Taxes Paid Related To Net Share Settlement Of Equity Awards
TaxesPaidRelatedToNetShareSettlementOfEquityAwards
-75000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
24000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
47000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
5514000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
70773000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
55676000
smlr Adjustments To Additional Paid In Capital Repurchase Of Warrants
AdjustmentsToAdditionalPaidInCapitalRepurchaseOfWarrants
1949000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
846000
smlr Taxes Paid Related To Net Share Settlement Of Equity Awards
TaxesPaidRelatedToNetShareSettlementOfEquityAwards
-247000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
24000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
61000
us-gaap Net Income Loss
NetIncomeLoss
16362000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
70773000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
78398000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
26000
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2536000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
588000
CY2024Q3 smlr Taxes Paid Related To Net Share Settlement Of Equity Awards
TaxesPaidRelatedToNetShareSettlementOfEquityAwards
-830000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
204000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
5609000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
85355000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
71795000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
150000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2536000
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
588000
smlr Taxes Paid Related To Net Share Settlement Of Equity Awards
TaxesPaidRelatedToNetShareSettlementOfEquityAwards
-874000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
295000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
348000
us-gaap Net Income Loss
NetIncomeLoss
11693000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
85355000
us-gaap Profit Loss
ProfitLoss
11693000
us-gaap Profit Loss
ProfitLoss
16362000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
480000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
439000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-353000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-478000
us-gaap Gain Loss On Sale Of Leased Assets Net Operating Leases
GainLossOnSaleOfLeasedAssetsNetOperatingLeases
-323000
us-gaap Gain Loss On Sale Of Leased Assets Net Operating Leases
GainLossOnSaleOfLeasedAssetsNetOperatingLeases
-355000
smlr Gain Loss On Disposition Of Inventory
GainLossOnDispositionOfInventory
-171000
us-gaap Debt Securities Trading Realized Gain
DebtSecuritiesTradingRealizedGain
307000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-21000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
203000
smlr Fair Value Adjustment Of Notes Held For Investment
FairValueAdjustmentOfNotesHeldForInvestment
-128000
smlr Fair Value Adjustment Of Notes Held For Investment
FairValueAdjustmentOfNotesHeldForInvestment
217000
us-gaap Crypto Asset Unrealized Gain Loss Nonoperating
CryptoAssetUnrealizedGainLossNonoperating
-3918000
us-gaap Share Based Compensation
ShareBasedCompensation
498000
us-gaap Share Based Compensation
ShareBasedCompensation
907000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
512000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2284000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-65000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-30000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-388000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
478000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-64000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-98000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
143000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-535000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
756000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2250000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-16000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-22000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-315000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-40000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
16983000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
16888000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
48000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
310000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
500000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
1000000
us-gaap Payment For Acquisition Crypto Asset
PaymentForAcquisitionCryptoAsset
68400000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
59719000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
57869000
us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
35000
us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
773000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-68983000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-233000
us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
1949000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2536000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
874000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
247000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
588000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
295000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
24000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1369000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2172000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-50631000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14483000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57332000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23014000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6701000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37497000
us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;font-weight:bold;margin-bottom:10pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt 0pt 10pt 0pt;">1.</td><td style="padding:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Basis of Presentation</b></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;">Semler Scientific, Inc., a Delaware corporation (“Semler” or “the Company”), prepared the unaudited interim financial statements included in this report in accordance with United States generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the audited financial statements and notes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2023 filed with the SEC on March 7, 2024 (the “Annual Report”). In the opinion of management, these financial statements include all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the Company’s financial position, results of operations and cash flows for the periods presented. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for any future period, including the full year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><b style="font-weight:bold;">Intangible Digital Assets</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;">The Company accounts for its digital assets, which are comprised solely of bitcoin, as indefinite-lived intangible assets in accordance with Accounting Standards Codification (“ASC”) 350, <i style="font-style:italic;">Intangibles—Goodwill and Other</i>. The Company has ownership of and control over its bitcoin and uses third-party custodial services at multiple locations that are geographically dispersed to store its bitcoin. The Company’s digital assets are initially recorded at cost and subsequently remeasured to fair value at the end of each reporting period, with changes recognized in net income.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;">The Company purchases bitcoins for long term investment. It intends to hold its digital assets for long term gains and treats them as long term capital assets for tax purposes. Unrealized gains/losses are treated as capital gains/losses for tax purposes. A valuation allowance is recorded for unrealized capital losses. See Note 10 to the Unaudited Condensed Financial Statements for additional information regarding the Company’s purchases and sales of digital assets. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;background:#ffffff;">Recently Issued Accounting Pronouncements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:6pt 0pt 0pt 0pt;">In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-09,<i style="font-style:italic;"> Income Taxes (Topic 740): Improvements to Income Tax Disclosures</i> (“ASU 2023-09”). ASU 2023-09 requires enhanced disclosures surrounding income taxes, particularly related to rate reconciliation and income taxes paid information. In particular, on an annual basis, companies will be required to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. Companies will also be required to disclose, on an annual basis, the amount of income taxes paid, disaggregated by federal, state, and foreign taxes, and also disaggregated by individual jurisdictions above a quantitative threshold. The standard is effective for the Company for annual periods beginning after December 15, 2024 on a prospective basis, with retrospective application permitted for all prior periods presented. Early adoption is permitted. The Company is currently evaluating the impact of this guidance on its disclosures.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Recently Adopted Accounting Pronouncement</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:35.3pt;background:#ffffff;margin:0pt;">In December 2023, the FASB issued ASU No. 2023-08, <i style="font-style:italic;">Intangibles—Goodwill and Other—Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets</i> (“ASU 2023-08”). ASU 2023-08 requires in-scope crypto assets to be measured at fair value in the statement of financial position, with gains and losses from changes in the fair value of such crypto assets recognized in net income each reporting period. ASU 2023-08 also requires certain interim and annual disclosures for crypto assets within the scope of the standard. The standard is effective for the Company for interim and annual periods beginning after December 15, 2024, with a cumulative-effect adjustment to the opening balance of retained earnings as of the beginning of the annual reporting period in which the Company adopts the guidance. Early adoption is permitted in any interim or annual period for which an entity's financial statements have not been issued as of the beginning of the annual reporting period. The Company early adopted <span style="-sec-ix-hidden:Hidden_3Np19frGOECByCeAJVVI8A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;background:#ffffff;">ASU 2023-08</span></span> in the </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;">second quarter ended June 30, 2024, effective retroactively as of January 1, 2024 with no cumulative-adjustment to the retained earnings as of the beginning of the annual period of adoption.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;background:#ffffff;margin:0pt 0pt 6pt 0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:10pt;visibility:hidden;">​</span></p>
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6667000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6125000
CY2024Q3 smlr Contract With Customer Accounts Receivable Net
ContractWithCustomerAccountsReceivableNet
4880000
CY2023Q4 smlr Contract With Customer Accounts Receivable Net
ContractWithCustomerAccountsReceivableNet
5966000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
266000
CY2024Q3 smlr Accounts Receivable Allowance For Credit Loss Additional Reserve
AccountsReceivableAllowanceForCreditLossAdditionalReserve
40000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
17000
smlr Accounts Receivable Allowance For Credit Loss Additional Reserve
AccountsReceivableAllowanceForCreditLossAdditionalReserve
71000
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
92000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
287000
CY2024Q3 us-gaap Inventory Net
InventoryNet
380000
CY2023Q4 us-gaap Inventory Net
InventoryNet
445000
CY2024Q3 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
2865000
CY2023Q4 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
3375000
CY2024Q3 us-gaap Property Subject To Or Available For Operating Lease Accumulated Depreciation
PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation
1128000
CY2023Q4 us-gaap Property Subject To Or Available For Operating Lease Accumulated Depreciation
PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation
1090000
CY2024Q3 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
1737000
CY2023Q4 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
2285000
CY2024Q3 us-gaap Operating Leases Income Statement Depreciation Expense On Property Subject To Or Held For Lease
OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease
71000
CY2023Q3 us-gaap Operating Leases Income Statement Depreciation Expense On Property Subject To Or Held For Lease
OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease
81000
us-gaap Operating Leases Income Statement Depreciation Expense On Property Subject To Or Held For Lease
OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease
261000
us-gaap Operating Leases Income Statement Depreciation Expense On Property Subject To Or Held For Lease
OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease
228000
CY2024Q3 smlr Assets For Lease Reduction To Accumulated Depreciation
AssetsForLeaseReductionToAccumulatedDepreciation
80000
CY2023Q3 smlr Assets For Lease Reduction To Accumulated Depreciation
AssetsForLeaseReductionToAccumulatedDepreciation
125000
smlr Assets For Lease Reduction To Accumulated Depreciation
AssetsForLeaseReductionToAccumulatedDepreciation
184000
smlr Assets For Lease Reduction To Accumulated Depreciation
AssetsForLeaseReductionToAccumulatedDepreciation
390000
CY2024Q3 us-gaap Gain Loss On Sale Of Leased Assets Net Operating Leases
GainLossOnSaleOfLeasedAssetsNetOperatingLeases
-4000
CY2023Q3 us-gaap Gain Loss On Sale Of Leased Assets Net Operating Leases
GainLossOnSaleOfLeasedAssetsNetOperatingLeases
-241000
us-gaap Gain Loss On Sale Of Leased Assets Net Operating Leases
GainLossOnSaleOfLeasedAssetsNetOperatingLeases
-323000
us-gaap Gain Loss On Sale Of Leased Assets Net Operating Leases
GainLossOnSaleOfLeasedAssetsNetOperatingLeases
-355000
CY2024Q3 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
1464000
CY2023Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
1544000
CY2024Q3 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
916000
CY2023Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
824000
CY2024Q3 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation
548000
CY2023Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation
720000
CY2024Q3 us-gaap Depreciation Excluding Lessor Asset Under Operating Lease
DepreciationExcludingLessorAssetUnderOperatingLease
72000
CY2023Q3 us-gaap Depreciation Excluding Lessor Asset Under Operating Lease
DepreciationExcludingLessorAssetUnderOperatingLease
80000
us-gaap Depreciation Excluding Lessor Asset Under Operating Lease
DepreciationExcludingLessorAssetUnderOperatingLease
219000
us-gaap Depreciation Excluding Lessor Asset Under Operating Lease
DepreciationExcludingLessorAssetUnderOperatingLease
211000
CY2024Q3 us-gaap Long Term Investments
LongTermInvestments
512000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
512000
CY2024Q3 smlr Debt Security Face Value
DebtSecurityFaceValue
5000000
CY2023Q4 us-gaap Debt Securities
DebtSecurities
4372000
CY2024Q3 us-gaap Notes Receivable Net
NotesReceivableNet
6100000
CY2023Q4 us-gaap Notes Receivable Net
NotesReceivableNet
5372000
CY2024Q3 smlr Debt Security Interest Income
DebtSecurityInterestIncome
139000
CY2023Q3 smlr Debt Security Interest Income
DebtSecurityInterestIncome
120000
smlr Debt Security Interest Income
DebtSecurityInterestIncome
396000
smlr Debt Security Interest Income
DebtSecurityInterestIncome
347000
smlr Debt Security Changes In Fair Value
DebtSecurityChangesInFairValue
128000
CY2024Q3 us-gaap Crypto Asset Number Of Units
CryptoAssetNumberOfUnits
1018
CY2024Q3 us-gaap Crypto Asset Cost
CryptoAssetCost
68400000
CY2024Q3 us-gaap Crypto Asset Fair Value
CryptoAssetFairValue
64482000
CY2024Q2 us-gaap Crypto Asset Fair Value
CryptoAssetFairValue
54945000
CY2024Q3 us-gaap Crypto Asset Addition
CryptoAssetAddition
8400000
us-gaap Crypto Asset Addition
CryptoAssetAddition
68400000
CY2024Q3 smlr Crypto Asset Unrealized Gain Net Nonoperating
CryptoAssetUnrealizedGainNetNonoperating
1137000
smlr Crypto Asset Unrealized Gain Net Nonoperating
CryptoAssetUnrealizedGainNetNonoperating
679000
us-gaap Crypto Asset Unrealized Loss Nonoperating
CryptoAssetUnrealizedLossNonoperating
4597000
CY2024Q3 us-gaap Crypto Asset Fair Value
CryptoAssetFairValue
64482000
CY2024Q3 us-gaap Crypto Asset Fair Value
CryptoAssetFairValue
64482000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
87000
CY2024Q3 smlr Long Term Deposits
LongTermDeposits
19000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
150000
CY2023Q4 smlr Miscellaneous Receivables
MiscellaneousReceivables
100000
CY2023Q4 smlr Long Term Deposits
LongTermDeposits
20000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3044000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2008000
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1678000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1991000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
536000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
503000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5258000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4502000
CY2024Q3 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
3105000
CY2023Q4 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
5465000
CY2024Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
3596000
CY2023Q4 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
10494000
CY2023Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
41373000
CY2024Q3 us-gaap Crypto Asset Cost
CryptoAssetCost
68400000
CY2024Q3 us-gaap Crypto Asset Fair Value
CryptoAssetFairValue
64482000
CY2020Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P61M
CY2020Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P61M
CY2024Q3 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P12M
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
false
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
22000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
22000
us-gaap Operating Lease Cost
OperatingLeaseCost
66000
us-gaap Operating Lease Cost
OperatingLeaseCost
66000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
24000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
71000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
95000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
93000
CY2024Q3 smlr Operating Lease Expenses In Excess Of Cash Payments
OperatingLeaseExpensesInExcessOfCashPayments
6000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
87000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
87000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
93000
CY2024Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.025
CY2024Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
6780000
CY2023Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
9539000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
20633000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
28462000
CY2024Q3 us-gaap Lease Practical Expedient Lessor Single Lease Component
LeasePracticalExpedientLessorSingleLeaseComponent
true
us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2024Q3 smlr Defined Contribution Plan Employer Match Amount
DefinedContributionPlanEmployerMatchAmount
85000
CY2023Q3 smlr Defined Contribution Plan Employer Match Amount
DefinedContributionPlanEmployerMatchAmount
102000
smlr Defined Contribution Plan Employer Match Amount
DefinedContributionPlanEmployerMatchAmount
219000
smlr Defined Contribution Plan Employer Match Amount
DefinedContributionPlanEmployerMatchAmount
307000
CY2024Q3 smlr Income Taxes Receivable Cares Act
IncomeTaxesReceivableCaresAct
1240000
smlr Employee Retention Payroll Tax Credit Claimed Cares Act
EmployeeRetentionPayrollTaxCreditClaimedCaresAct
0
CY2024Q3 smlr Employee Retention Payroll Tax Credit Claimed Cares Act
EmployeeRetentionPayrollTaxCreditClaimedCaresAct
0
CY2023 smlr Employee Retention Payroll Tax Credit Claimed Cares Act
EmployeeRetentionPayrollTaxCreditClaimedCaresAct
0
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 smlr Number Of Votes For Each Share
NumberOfVotesForEachShare
1
CY2024Q2 smlr Sale Of Stock Value Authorized
SaleOfStockValueAuthorized
150000000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
6546
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
150000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
23868
smlr Share Based Payment Arrangement Shares Issued Net Of Shares For Tax Withholdings
ShareBasedPaymentArrangementSharesIssuedNetOfSharesForTaxWithholdings
15229
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
846000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1021785
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.84
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y9M3D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
41333000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
173700
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
23.04
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
6650
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
176285
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.68
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1012550
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.21
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y7M9D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
16615000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
840815
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.92
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y7M13D
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
16534000
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
204000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
47000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
498000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
907000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
766000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1474000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3615000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4924000
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.1202
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2362
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2109
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2313
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
582000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
470000
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
137000
CY2023 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
87000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7045108
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5609000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.80
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6717301
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5514000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.82
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
725980
CY2024Q3 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1100935
CY2023Q3 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7771088
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
5609000
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7818236
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
5514000
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6961095
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
11693000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.68
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6708675
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
16362000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.44
smlr Amount Of Dilutive Securities Common Stock Warrants
AmountOfDilutiveSecuritiesCommonStockWarrants
0
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
21608
smlr Amount Of Dilutive Securities Common Stock Warrants
AmountOfDilutiveSecuritiesCommonStockWarrants
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
822255
us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1117107
us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7783350
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
11693000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.50
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7847390
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
16362000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.09
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001554859-24-000040-index-headers.html Edgar Link pending
0001554859-24-000040-index.html Edgar Link pending
0001554859-24-000040.txt Edgar Link pending
0001554859-24-000040-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
smlr-20240930.xsd Edgar Link pending
smlr-20240930x10q.htm Edgar Link pending
smlr-20240930xex31d1.htm Edgar Link pending
smlr-20240930xex31d2.htm Edgar Link pending
smlr-20240930xex32d1.htm Edgar Link pending
smlr-20240930_cal.xml Edgar Link unprocessable
smlr-20240930_def.xml Edgar Link unprocessable
smlr-20240930_lab.xml Edgar Link unprocessable
smlr-20240930_pre.xml Edgar Link unprocessable
smlr-20240930x10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable